M16.11, Unilateral primary osteoarthritis, right hipICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
CGS-J15-L40232, Total Joint Arthroplasty
J15
CGS-J18-L40232, Total Joint Arthroplasty
J18
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
A54923, Billing and Coding: Bariatric Surgery for Treatment of Co-Morbidities Conditions Related to Morbid Obesity
J5
A59811, Billing and Coding: Total Joint Arthroplasty
J5
WPS-J5-L39911, Total Joint Arthroplasty
J5
NGS-J6-L40334, Erythropoiesis Stimulating Agents
J6
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
NGS-J6-L40333, Erythropoiesis Stimulating Agents
J6
WPS-J8-L39911, Total Joint Arthroplasty
J8
A57145, Billing and Coding: Surgical Management of Morbid Obesity
J9
A57765, Billing and Coding: Major Joint Replacement (Hip and Knee)
J9
FIRST_COAST-L33618, Major Joint Replacement (Hip and Knee)
J9
A59764, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J9
FIRST_COAST-L33411, Surgical Management of Morbid Obesity
J9
NOVITAS-JH-L36007, Lower Extremity Major Joint Replacement (Hip and Knee)
JH
NOVITAS-JH-L35022, Bariatric Surgical Management of Morbid Obesity
JH
NGS-JK-L40334, Erythropoiesis Stimulating Agents
JK
NGS-JK-L40333, Erythropoiesis Stimulating Agents
JK
A59766, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JL
Ask Backwork about documentation requirements, denial risks, or coverage in your state.